Centene Names Lincoln Financial's Chris Neczypor as Next CFO in Planned Leadership Transition
The managed care provider announced Drew Asher will step down as CFO at year-end after helping expand revenue from $126 billion to $195 billion during his tenure.
Leadership Transition Announced
Centene Corporation announced a planned chief financial officer transition, with Drew Asher stepping down from the CFO role on December 31, 2026, and retiring from the company at the end of 2027 (8-K filing, 2026-08-17). Chris Neczypor will assume the Executive Vice President and Chief Financial Officer role on January 1, 2027.
Neczypor will join Centene in September to work alongside Asher, who will remain with the $32 billion market cap managed care company through 2027 "to support a variety of strategic initiatives and ensure a smooth transition" (8-K filing, 2026-08-17).
Incoming CFO Background
Neczypor brings extensive experience in corporate finance and strategy from Lincoln Financial, where he served as Executive Vice President and Chief Financial Officer. According to the filing, he joined Lincoln in 2018 and held multiple leadership positions, including Chief Strategy Officer and roles spanning investments, strategic planning, and enterprise transformation (8-K filing, 2026-08-17).
Prior to Lincoln Financial, Neczypor spent more than a decade in investment and financial services, including as an equity research analyst at Goldman Sachs and as an investor at institutional asset management firms (8-K filing, 2026-08-17).
"Chris brings a proven track record of strengthening financial performance, optimizing operations and creating long-term shareholder value," said CEO Sarah M. London in the announcement (8-K filing, 2026-08-17).
Asher's Tenure
Asher has served as CFO since 2021, guiding Centene through a period of significant expansion. The company grew from approximately $126 billion in revenue in 2021 to approximately $195 billion in 2025, representing a 55% increase during "a period of transformation across the healthcare industry" (8-K filing, 2026-08-17).
"I am incredibly proud of how Centene navigated through unprecedented change while remaining disciplined in execution and focused on long-term value," Asher stated (8-K filing, 2026-08-17).
Asher's career spans over three decades of financial and healthcare industry leadership, according to the filing.
Guidance Reaffirmed
Centene reaffirmed its previously issued full-year 2026 adjusted diluted earnings per share guidance of greater than $4.80 and all associated 2026 full-year guidance metrics provided in its July 28, 2026 second quarter earnings release (8-K filing, 2026-08-17).
The Fortune 500 company describes itself as "a leading healthcare enterprise" providing services to government-sponsored and commercial healthcare programs, with a focus on under-insured and uninsured individuals. Centene serves more than 1 in 15 individuals across the nation, including Medicaid and Medicare members (8-K filing, 2026-08-17).
MarginX data shows Centene is scheduled to report third quarter 2026 results on October 27, 2026. Recent insider activity includes equity awards to executives Paul J. Diaz and Lauren M. Tyler.
This article was generated by MarginX from the 8-K filing on 2026-08-17. It is not investment advice.